TrialPediatric blood & cancer2021

Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening trial.

Adam S Levy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.